SecSonar.com

Ainos, Inc. (AIMD)

Ainos, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Ainos, Inc. (AIMD) is a Biotechnology company based in US with a market capitalization of $11.4M. Revenue grew 498.9% year-over-year and free cash flow was negative at -$4.6M. This page tracks AIMD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 44 employees · IPO Jan 8, 2021

Valuation

Valuation & price

$1.75 · as of May 15, 2026 · -58.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.50

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$4.13$2.73$1.34Jul 25Dec 25Jul 26Jul 7, 25$3.30Jul 9, 25$3.19Jul 11, 25$2.98Jul 15, 25$2.86Jul 17, 25$2.80Jul 21, 25$2.64Jul 23, 25$2.70Jul 25, 25$2.58Jul 29, 25$2.44Jul 31, 25$2.60Aug 4, 25$2.47Aug 6, 25$3.26Aug 11, 25$3.26Aug 13, 25$3.36Aug 15, 25$3.46Aug 19, 25$3.34Aug 21, 25$3.46Aug 25, 25$3.84Aug 27, 25$3.80Aug 29, 25$3.82Sep 3, 25$3.74Sep 5, 25$3.49Sep 9, 25$3.38Sep 11, 25$3.61Sep 16, 25$3.45Sep 18, 25$3.51Sep 22, 25$3.80Sep 24, 25$3.42Sep 26, 25$3.48Sep 30, 25$3.47Oct 2, 25$3.59Oct 6, 25$3.86Oct 8, 25$4.01Oct 10, 25$3.77Oct 14, 25$4.13Oct 16, 25$4.03Oct 21, 25$3.64Oct 23, 25$3.62Oct 27, 25$3.60Oct 29, 25$3.64Oct 31, 25$3.30Nov 4, 25$3.28Nov 6, 25$2.92Nov 10, 25$2.80Nov 12, 25$2.86Nov 14, 25$2.21Nov 18, 25$2.23Nov 20, 25$1.91Nov 25, 25$2.10Nov 28, 25$2.10Dec 2, 25$2.06Dec 4, 25$2.50Dec 8, 25$2.20Dec 10, 25$2.16Dec 12, 25$2.27Dec 16, 25$2.15Dec 18, 25$2.05Dec 22, 25$2.06Dec 24, 25$1.98Dec 29, 25$1.90Jan 2, 26$1.75Jan 6, 26$1.78Jan 8, 26$1.79Jan 12, 26$1.90Jan 14, 26$1.92Jan 16, 26$1.90Jan 21, 26$1.85Jan 23, 26$1.84Jan 27, 26$1.72Jan 29, 26$2.35Feb 2, 26$2.28Feb 4, 26$2.04Feb 9, 26$1.88Feb 11, 26$1.74Feb 13, 26$1.52Feb 18, 26$1.35Feb 20, 26$1.34Feb 24, 26$1.63Feb 26, 26$1.66Mar 2, 26$1.58Mar 4, 26$1.51Mar 6, 26$1.38Mar 10, 26$1.53Mar 12, 26$1.46Mar 17, 26$1.46Mar 19, 26$1.45Mar 23, 26$1.60Mar 25, 26$1.44Mar 27, 26$1.39Mar 31, 26$1.39Apr 2, 26$1.44Apr 7, 26$1.48Apr 9, 26$1.69Apr 13, 26$1.64Apr 15, 26$1.61Apr 17, 26$1.97Apr 22, 26$1.85Apr 24, 26$1.77Apr 28, 26$1.80Apr 30, 26$1.74May 4, 26$1.71May 6, 26$1.77May 8, 26$1.70May 12, 26$1.68May 14, 26$1.72May 18, 26$1.66May 20, 26$1.50May 22, 26$1.53May 28, 26$2.74Jun 1, 26$2.33Jun 3, 26$2.20Jun 5, 26$1.95Jun 9, 26$2.04Jun 11, 26$1.92Jun 15, 26$1.84Jun 17, 26$2.04Jun 22, 26$1.86Jun 24, 26$1.80Jun 26, 26$1.73Jul 2, 26$1.87
$1.2952-week range$4.25
Loading valuation history…

Fundamentals

Key fundamentals

$11.4M

Market cap

498.9%

Revenue growth (YoY)

-3767.2%

Gross margin

-$4.6M

Free cash flow (USD)

$10.6M

Net debt

-55.1%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$250.9KFY 2018$77.7KFY 2019$11.7KFY 2020$16.6KFY 2021$594.6KFY 2022$3.5MFY 2023$122.1KFY 2024$20.7KFY 2025$124.2K
$0$124.2K

Free cash flow by year

2016 → 2025

FY 2016$-669.1KFY 2017$-591.8KFY 2018$-1.0MFY 2019$-922.6KFY 2020$-506.8KFY 2021$-1.4MFY 2022$-3.7MFY 2023$-4.8MFY 2024$-5.8MFY 2025$-4.6M
-$669.1K-$4.6M

Gross margin by year

2021 → 2025

FY 202169.0%FY 202239.9%FY 2023-207.8%FY 2024-153.7%FY 2025-3767.2%
69.0%-3767.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing

Questions

Frequently asked questions

What is Ainos, Inc.'s market cap?

Ainos, Inc. (AIMD) has a market capitalization of $11.4M.

What is AIMD's P/E ratio?

A meaningful P/E ratio is not available for AIMD — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is AIMD's price-to-book (P/B) ratio?

AIMD trades at 1.50 times book value per share.

Are insiders buying AIMD stock?

SEC Form 4 filings show no open-market insider buys at Ainos, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

VYNE

VYNE Therapeutics Inc.

$11.4M

KPRX

Kiora Pharmaceuticals, Inc.

$11.9M

OSRH

OSR Holdings, Inc.

$10.8M

LEXX

Lexaria Bioscience Corp.

$12.2M

ICU

SeaStar Medical Holding Corporation

$10.5M

HIND

Vyome Holdings, Inc.

$13M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.